Martingale Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-19,153
| Closed | -$144K | – | 868 |
|
|
2021
Q4 | $144K | Hold |
19,153
| – | – | ﹤0.01% | 806 |
|
|
2021
Q3 | $173K | Buy |
19,153
+1,200
| +7% | +$10.8K | ﹤0.01% | 829 |
|
|
2021
Q2 | $215K | Buy |
+17,953
| New | +$215K | ﹤0.01% | 790 |
|
|
2020
Q2 | – | Sell |
-19,050
| Closed | -$122K | – | 1066 |
|
|
2020
Q1 | $122K | Sell |
19,050
-31,800
| -63% | -$204K | ﹤0.01% | 942 |
|
|
2019
Q4 | $426K | Buy |
50,850
+1,700
| +3% | +$14.2K | ﹤0.01% | 888 |
|
|
2019
Q3 | $445K | Buy |
49,150
+11,001
| +29% | +$99.6K | ﹤0.01% | 894 |
|
|
2019
Q2 | $411K | Buy |
+38,149
| New | +$411K | ﹤0.01% | 915 |
|